OX40/TRAIL fusion proteins
- 专利权人:
- Mark L. Tykocinski
- 发明人:
- Mark L. Tykocinski
- 申请号：
- US13256401
- 公开号：
- US09221895B2
- 申请日:
- 2010.03.11
- 申请国别(地区):
- US
- 年份:
- 2015
- 代理人:
- 摘要：
- Fusion proteins which act on the OX40/TRAIL signaling axes are provided. The proteins are useful in the treatment or amelioration of autoimmune diseases, particularly multiple sclerosis, and alloimmune diseases, as well as cancer.
- 来源网站：
- 中国工程科技知识中心
